ArticlePsycho-oncology2025
Psychometric Properties of the Fear of Progression Questionnaire for Children in Two German Samples (Acute Treatment and Follow-Up Care).
Article in Psycho-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An intervention for fear of progression in childhood cancer patients and their parents: feasibility and preliminary efficacy in a pilot randomised controlled trial.BMC pediatrics · 2026Trial
- Fear of Progression in Pediatric Cancer Patients and Their Parents: Trajectories, Prevalence, and Correlates Across Acute Treatment and Follow-Up Care.Psycho-oncology · 2026Article
- Psychometric Properties of the Fear of Progression Questionnaire for Children in Two German Samples (Acute Treatment and Follow-Up Care).Psycho-oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundFear of progression (FoP) is among the most prevalent psychosocial burdens in paediatric oncology. Empirical evidence suggests that FoP is particularly pronounced during acute treatment and often persists into follow-up care. It is associated with heightened perception of physical symptoms, increased post-traumatic stress symptoms, more negative illness perceptions, and reduced quality of life (QoL). Consequently, a comprehensive diagnostic instrument is essential to assess FoP in children with cancer.
objectiveThis study aimed to prospectively validate the German self-report version of the Fear of Progression Questionnaire for Children (FoP-Q-SF/C) aged 7-18 years both during acute treatment and in follow-up care.
methodsA total of 116 children participated in the study, including 39 undergoing acute treatment and 77 in follow-up care. Participants completed the FoP-Q-SF/C. Factor analyses were conducted, and associations between FoP and QoL, illness perceptions, posttraumatic stress symptoms, time since diagnosis, cancer type and treatment modality were examined.
resultsAll items were applicable in children. The FoP-Q-SF/C demonstrated high internal consistency and good convergent, criterion and divergent validity. Consistent with previous research, factor analysis supported a one-factor structure, although findings suggest potential for structural refinement.
conclusionsThe FoP-Q-SF/C is a reliable and valid questionnaire for assessing FoP in children with cancer across different treatment phases. It serves as a valuable screening instrument to identify children at risk for elevated psychosocial distress and to guide targeted psychosocial interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.